Last edition
News about "Gaymed Labs investment deal"
Zyax Chem Buys 26 Percent Stake in Gaymed Labs
Zyax Chem acquires 26 percent stake in Gaymed Labs, securing board representation and boosting expansion in the ophthalmic segment.
Gaymed Labs Investment Deal | 22/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members